# Dose-response Study of Spinally Administered Ropivacaine for Caesarean Section in Tall Parturients

> **NCT03936790** · NA · ENROLLING_BY_INVITATION · sponsor: **Paraskevi Matsota** · enrollment: 40 (estimated)

## Conditions studied

- Regional Anaesthesia
- Cesarean Section

## Interventions

- **OTHER:** Ropivacaine
- **OTHER:** Fentanyl

## Key facts

- **NCT ID:** NCT03936790
- **Lead sponsor:** Paraskevi Matsota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2019-06-02
- **Primary completion:** 2024-10-20
- **Final completion:** 2025-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03936790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03936790, "Dose-response Study of Spinally Administered Ropivacaine for Caesarean Section in Tall Parturients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03936790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*